No Data
No Data
Simple Testing: 2024 Semi-Annual Report
Simple Testing: 2024 Semi-Annual Report Summary
Shibokes Testing (301228.SZ) announced its performance for the first half of the year, with a net loss of 26.3325 million yuan.
Shide Testing (301228.SZ) released the 2024 semi-annual report, during the reporting period the company achieved revenue of...
Shibuda Testing (301228.SZ): Net loss of 26.3325 million yuan in the first half of the year, with a narrower year-on-year loss.
Gelonghui announced the 2024 interim report on August 28. The report shows that the operating revenue for the reporting period is 0.199 billion yuan, a year-on-year increase of 17.13%. The net profit attributable to shareholders of the listed company is -26.3325 million yuan, narrowing the loss. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses is -27.3536 million yuan. The basic earnings per share is -0.22675 yuan.
Shibo Testing (301228.SZ): The company has no qualifications for monkeypox testing.
On August 20th, Gelunhui reported that Shiborui Detection (301228.SZ) stated on the investor interaction platform that the company has no smallpox detection qualification. The company has the qualifications and ability to test edible vegetable oils, pollutants in edible vegetable oils, and hydrocarbon mineral oils.
As of July 31st, there were 12,269 shareholders in the company of Shenzhen Shibao Testing Ltd. (301228.SZ).
On August 5th, Gelonhui reported that in the investor interaction platform, the latest total number of shareholders of Shibuo Detection (301228.SZ) as of July 31, 2024 is 12,269 (including credit accounts).
No Data